[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Anti-PD-1 Antibody Market, Global Outlook and Forecast 2022-2028

March 2022 | 115 pages | ID: AF0146F824D7EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Anti-PD-1 Antibody is used to inhibit PD-1 and its downstream signaling pathways.

This report contains market size and forecasts of Anti-PD-1 Antibody in global, including the following market information:

Global Anti-PD-1 Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Anti-PD-1 Antibody Market Sales, 2017-2022, 2023-2028, (Kg)

Global top five Anti-PD-1 Antibody companies in 2021 (%)

The global Anti-PD-1 Antibody market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monoclonal Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anti-PD-1 Antibody include Bio X Cell, Thermo Fisher, InvivoGen, BioVision Inc, Abcam, Bristol-Myers Squibb (BMS), Merck, Ono Pharmaceutical Co., Ltd and Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-PD-1 Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-PD-1 Antibody Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Anti-PD-1 Antibody Market Segment Percentages, by Type, 2021 (%)
  • Monoclonal
  • Polyclonal
Global Anti-PD-1 Antibody Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Anti-PD-1 Antibody Market Segment Percentages, by Application, 2021 (%)
  • IHC-P
  • ICC/IF
  • WB
  • Flow Cytometry
  • ELISA
Global Anti-PD-1 Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Anti-PD-1 Antibody Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-PD-1 Antibody revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Anti-PD-1 Antibody revenues share in global market, 2021 (%)

Key companies Anti-PD-1 Antibody sales in global market, 2017-2022 (Estimated), (Kg)

Key companies Anti-PD-1 Antibody sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Bio X Cell
  • Thermo Fisher
  • InvivoGen
  • BioVision Inc
  • Abcam
  • Bristol-Myers Squibb (BMS)
  • Merck
  • Ono Pharmaceutical Co., Ltd
  • Lilly
  • Chugai Pharmaceutical Co., Ltd
  • BeiGene
  • Abbvie
  • TG Therapeutics, Inc
  • Novartis
  • Arcus Biosciences
  • Sino Biological Inc
  • 3SBio Inc
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-PD-1 Antibody Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-PD-1 Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-PD-1 ANTIBODY OVERALL MARKET SIZE

2.1 Global Anti-PD-1 Antibody Market Size: 2021 VS 2028
2.2 Global Anti-PD-1 Antibody Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Anti-PD-1 Antibody Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Anti-PD-1 Antibody Players in Global Market
3.2 Top Global Anti-PD-1 Antibody Companies Ranked by Revenue
3.3 Global Anti-PD-1 Antibody Revenue by Companies
3.4 Global Anti-PD-1 Antibody Sales by Companies
3.5 Global Anti-PD-1 Antibody Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Anti-PD-1 Antibody Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Anti-PD-1 Antibody Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-PD-1 Antibody Players in Global Market
  3.8.1 List of Global Tier 1 Anti-PD-1 Antibody Companies
  3.8.2 List of Global Tier 2 and Tier 3 Anti-PD-1 Antibody Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Anti-PD-1 Antibody Market Size Markets, 2021 & 2028
  4.1.2 Monoclonal
  4.1.3 Polyclonal
4.2 By Type - Global Anti-PD-1 Antibody Revenue & Forecasts
  4.2.1 By Type - Global Anti-PD-1 Antibody Revenue, 2017-2022
  4.2.2 By Type - Global Anti-PD-1 Antibody Revenue, 2023-2028
  4.2.3 By Type - Global Anti-PD-1 Antibody Revenue Market Share, 2017-2028
4.3 By Type - Global Anti-PD-1 Antibody Sales & Forecasts
  4.3.1 By Type - Global Anti-PD-1 Antibody Sales, 2017-2022
  4.3.2 By Type - Global Anti-PD-1 Antibody Sales, 2023-2028
  4.3.3 By Type - Global Anti-PD-1 Antibody Sales Market Share, 2017-2028
4.4 By Type - Global Anti-PD-1 Antibody Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-PD-1 Antibody Market Size, 2021 & 2028
  5.1.2 IHC-P
  5.1.3 ICC/IF
  5.1.4 WB
  5.1.5 Flow Cytometry
  5.1.6 ELISA
5.2 By Application - Global Anti-PD-1 Antibody Revenue & Forecasts
  5.2.1 By Application - Global Anti-PD-1 Antibody Revenue, 2017-2022
  5.2.2 By Application - Global Anti-PD-1 Antibody Revenue, 2023-2028
  5.2.3 By Application - Global Anti-PD-1 Antibody Revenue Market Share, 2017-2028
5.3 By Application - Global Anti-PD-1 Antibody Sales & Forecasts
  5.3.1 By Application - Global Anti-PD-1 Antibody Sales, 2017-2022
  5.3.2 By Application - Global Anti-PD-1 Antibody Sales, 2023-2028
  5.3.3 By Application - Global Anti-PD-1 Antibody Sales Market Share, 2017-2028
5.4 By Application - Global Anti-PD-1 Antibody Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti-PD-1 Antibody Market Size, 2021 & 2028
6.2 By Region - Global Anti-PD-1 Antibody Revenue & Forecasts
  6.2.1 By Region - Global Anti-PD-1 Antibody Revenue, 2017-2022
  6.2.2 By Region - Global Anti-PD-1 Antibody Revenue, 2023-2028
  6.2.3 By Region - Global Anti-PD-1 Antibody Revenue Market Share, 2017-2028
6.3 By Region - Global Anti-PD-1 Antibody Sales & Forecasts
  6.3.1 By Region - Global Anti-PD-1 Antibody Sales, 2017-2022
  6.3.2 By Region - Global Anti-PD-1 Antibody Sales, 2023-2028
  6.3.3 By Region - Global Anti-PD-1 Antibody Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Anti-PD-1 Antibody Revenue, 2017-2028
  6.4.2 By Country - North America Anti-PD-1 Antibody Sales, 2017-2028
  6.4.3 US Anti-PD-1 Antibody Market Size, 2017-2028
  6.4.4 Canada Anti-PD-1 Antibody Market Size, 2017-2028
  6.4.5 Mexico Anti-PD-1 Antibody Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Anti-PD-1 Antibody Revenue, 2017-2028
  6.5.2 By Country - Europe Anti-PD-1 Antibody Sales, 2017-2028
  6.5.3 Germany Anti-PD-1 Antibody Market Size, 2017-2028
  6.5.4 France Anti-PD-1 Antibody Market Size, 2017-2028
  6.5.5 U.K. Anti-PD-1 Antibody Market Size, 2017-2028
  6.5.6 Italy Anti-PD-1 Antibody Market Size, 2017-2028
  6.5.7 Russia Anti-PD-1 Antibody Market Size, 2017-2028
  6.5.8 Nordic Countries Anti-PD-1 Antibody Market Size, 2017-2028
  6.5.9 Benelux Anti-PD-1 Antibody Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Anti-PD-1 Antibody Revenue, 2017-2028
  6.6.2 By Region - Asia Anti-PD-1 Antibody Sales, 2017-2028
  6.6.3 China Anti-PD-1 Antibody Market Size, 2017-2028
  6.6.4 Japan Anti-PD-1 Antibody Market Size, 2017-2028
  6.6.5 South Korea Anti-PD-1 Antibody Market Size, 2017-2028
  6.6.6 Southeast Asia Anti-PD-1 Antibody Market Size, 2017-2028
  6.6.7 India Anti-PD-1 Antibody Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Anti-PD-1 Antibody Revenue, 2017-2028
  6.7.2 By Country - South America Anti-PD-1 Antibody Sales, 2017-2028
  6.7.3 Brazil Anti-PD-1 Antibody Market Size, 2017-2028
  6.7.4 Argentina Anti-PD-1 Antibody Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Anti-PD-1 Antibody Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Anti-PD-1 Antibody Sales, 2017-2028
  6.8.3 Turkey Anti-PD-1 Antibody Market Size, 2017-2028
  6.8.4 Israel Anti-PD-1 Antibody Market Size, 2017-2028
  6.8.5 Saudi Arabia Anti-PD-1 Antibody Market Size, 2017-2028
  6.8.6 UAE Anti-PD-1 Antibody Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Bio X Cell
  7.1.1 Bio X Cell Corporate Summary
  7.1.2 Bio X Cell Business Overview
  7.1.3 Bio X Cell Anti-PD-1 Antibody Major Product Offerings
  7.1.4 Bio X Cell Anti-PD-1 Antibody Sales and Revenue in Global (2017-2022)
  7.1.5 Bio X Cell Key News
7.2 Thermo Fisher
  7.2.1 Thermo Fisher Corporate Summary
  7.2.2 Thermo Fisher Business Overview
  7.2.3 Thermo Fisher Anti-PD-1 Antibody Major Product Offerings
  7.2.4 Thermo Fisher Anti-PD-1 Antibody Sales and Revenue in Global (2017-2022)
  7.2.5 Thermo Fisher Key News
7.3 InvivoGen
  7.3.1 InvivoGen Corporate Summary
  7.3.2 InvivoGen Business Overview
  7.3.3 InvivoGen Anti-PD-1 Antibody Major Product Offerings
  7.3.4 InvivoGen Anti-PD-1 Antibody Sales and Revenue in Global (2017-2022)
  7.3.5 InvivoGen Key News
7.4 BioVision Inc
  7.4.1 BioVision Inc Corporate Summary
  7.4.2 BioVision Inc Business Overview
  7.4.3 BioVision Inc Anti-PD-1 Antibody Major Product Offerings
  7.4.4 BioVision Inc Anti-PD-1 Antibody Sales and Revenue in Global (2017-2022)
  7.4.5 BioVision Inc Key News
7.5 Abcam
  7.5.1 Abcam Corporate Summary
  7.5.2 Abcam Business Overview
  7.5.3 Abcam Anti-PD-1 Antibody Major Product Offerings
  7.5.4 Abcam Anti-PD-1 Antibody Sales and Revenue in Global (2017-2022)
  7.5.5 Abcam Key News
7.6 Bristol-Myers Squibb (BMS)
  7.6.1 Bristol-Myers Squibb (BMS) Corporate Summary
  7.6.2 Bristol-Myers Squibb (BMS) Business Overview
  7.6.3 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Major Product Offerings
  7.6.4 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales and Revenue in Global (2017-2022)
  7.6.5 Bristol-Myers Squibb (BMS) Key News
7.7 Merck
  7.7.1 Merck Corporate Summary
  7.7.2 Merck Business Overview
  7.7.3 Merck Anti-PD-1 Antibody Major Product Offerings
  7.7.4 Merck Anti-PD-1 Antibody Sales and Revenue in Global (2017-2022)
  7.7.5 Merck Key News
7.8 Ono Pharmaceutical Co., Ltd
  7.8.1 Ono Pharmaceutical Co., Ltd Corporate Summary
  7.8.2 Ono Pharmaceutical Co., Ltd Business Overview
  7.8.3 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Major Product Offerings
  7.8.4 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales and Revenue in Global (2017-2022)
  7.8.5 Ono Pharmaceutical Co., Ltd Key News
7.9 Lilly
  7.9.1 Lilly Corporate Summary
  7.9.2 Lilly Business Overview
  7.9.3 Lilly Anti-PD-1 Antibody Major Product Offerings
  7.9.4 Lilly Anti-PD-1 Antibody Sales and Revenue in Global (2017-2022)
  7.9.5 Lilly Key News
7.10 Chugai Pharmaceutical Co., Ltd
  7.10.1 Chugai Pharmaceutical Co., Ltd Corporate Summary
  7.10.2 Chugai Pharmaceutical Co., Ltd Business Overview
  7.10.3 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Major Product Offerings
  7.10.4 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales and Revenue in Global (2017-2022)
  7.10.5 Chugai Pharmaceutical Co., Ltd Key News
7.11 BeiGene
  7.11.1 BeiGene Corporate Summary
  7.11.2 BeiGene Anti-PD-1 Antibody Business Overview
  7.11.3 BeiGene Anti-PD-1 Antibody Major Product Offerings
  7.11.4 BeiGene Anti-PD-1 Antibody Sales and Revenue in Global (2017-2022)
  7.11.5 BeiGene Key News
7.12 Abbvie
  7.12.1 Abbvie Corporate Summary
  7.12.2 Abbvie Anti-PD-1 Antibody Business Overview
  7.12.3 Abbvie Anti-PD-1 Antibody Major Product Offerings
  7.12.4 Abbvie Anti-PD-1 Antibody Sales and Revenue in Global (2017-2022)
  7.12.5 Abbvie Key News
7.13 TG Therapeutics, Inc
  7.13.1 TG Therapeutics, Inc Corporate Summary
  7.13.2 TG Therapeutics, Inc Anti-PD-1 Antibody Business Overview
  7.13.3 TG Therapeutics, Inc Anti-PD-1 Antibody Major Product Offerings
  7.13.4 TG Therapeutics, Inc Anti-PD-1 Antibody Sales and Revenue in Global (2017-2022)
  7.13.5 TG Therapeutics, Inc Key News
7.14 Novartis
  7.14.1 Novartis Corporate Summary
  7.14.2 Novartis Business Overview
  7.14.3 Novartis Anti-PD-1 Antibody Major Product Offerings
  7.14.4 Novartis Anti-PD-1 Antibody Sales and Revenue in Global (2017-2022)
  7.14.5 Novartis Key News
7.15 Arcus Biosciences
  7.15.1 Arcus Biosciences Corporate Summary
  7.15.2 Arcus Biosciences Business Overview
  7.15.3 Arcus Biosciences Anti-PD-1 Antibody Major Product Offerings
  7.15.4 Arcus Biosciences Anti-PD-1 Antibody Sales and Revenue in Global (2017-2022)
  7.15.5 Arcus Biosciences Key News
7.16 Sino Biological Inc
  7.16.1 Sino Biological Inc Corporate Summary
  7.16.2 Sino Biological Inc Business Overview
  7.16.3 Sino Biological Inc Anti-PD-1 Antibody Major Product Offerings
  7.16.4 Sino Biological Inc Anti-PD-1 Antibody Sales and Revenue in Global (2017-2022)
  7.16.5 Sino Biological Inc Key News
7.17 3SBio Inc
  7.17.1 3SBio Inc Corporate Summary
  7.17.2 3SBio Inc Business Overview
  7.17.3 3SBio Inc Anti-PD-1 Antibody Major Product Offerings
  7.17.4 3SBio Inc Anti-PD-1 Antibody Sales and Revenue in Global (2017-2022)
  7.17.5 3SBio Inc Key News

8 GLOBAL ANTI-PD-1 ANTIBODY PRODUCTION CAPACITY, ANALYSIS

8.1 Global Anti-PD-1 Antibody Production Capacity, 2017-2028
8.2 Anti-PD-1 Antibody Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-PD-1 Antibody Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ANTI-PD-1 ANTIBODY SUPPLY CHAIN ANALYSIS

10.1 Anti-PD-1 Antibody Industry Value Chain
10.2 Anti-PD-1 Antibody Upstream Market
10.3 Anti-PD-1 Antibody Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Anti-PD-1 Antibody Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Anti-PD-1 Antibody in Global Market
Table 2. Top Anti-PD-1 Antibody Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Anti-PD-1 Antibody Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Anti-PD-1 Antibody Revenue Share by Companies, 2017-2022
Table 5. Global Anti-PD-1 Antibody Sales by Companies, (Kg), 2017-2022
Table 6. Global Anti-PD-1 Antibody Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Anti-PD-1 Antibody Price (2017-2022) & (USD/g)
Table 8. Global Manufacturers Anti-PD-1 Antibody Product Type
Table 9. List of Global Tier 1 Anti-PD-1 Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-PD-1 Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-PD-1 Antibody Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Anti-PD-1 Antibody Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Anti-PD-1 Antibody Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Anti-PD-1 Antibody Sales (Kg), 2017-2022
Table 15. By Type - Global Anti-PD-1 Antibody Sales (Kg), 2023-2028
Table 16. By Application – Global Anti-PD-1 Antibody Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Anti-PD-1 Antibody Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Anti-PD-1 Antibody Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Anti-PD-1 Antibody Sales (Kg), 2017-2022
Table 20. By Application - Global Anti-PD-1 Antibody Sales (Kg), 2023-2028
Table 21. By Region – Global Anti-PD-1 Antibody Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Anti-PD-1 Antibody Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Anti-PD-1 Antibody Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Anti-PD-1 Antibody Sales (Kg), 2017-2022
Table 25. By Region - Global Anti-PD-1 Antibody Sales (Kg), 2023-2028
Table 26. By Country - North America Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Anti-PD-1 Antibody Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Anti-PD-1 Antibody Sales, (Kg), 2017-2022
Table 29. By Country - North America Anti-PD-1 Antibody Sales, (Kg), 2023-2028
Table 30. By Country - Europe Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Anti-PD-1 Antibody Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Anti-PD-1 Antibody Sales, (Kg), 2017-2022
Table 33. By Country - Europe Anti-PD-1 Antibody Sales, (Kg), 2023-2028
Table 34. By Region - Asia Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Anti-PD-1 Antibody Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Anti-PD-1 Antibody Sales, (Kg), 2017-2022
Table 37. By Region - Asia Anti-PD-1 Antibody Sales, (Kg), 2023-2028
Table 38. By Country - South America Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Anti-PD-1 Antibody Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Anti-PD-1 Antibody Sales, (Kg), 2017-2022
Table 41. By Country - South America Anti-PD-1 Antibody Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Anti-PD-1 Antibody Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Anti-PD-1 Antibody Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Anti-PD-1 Antibody Sales, (Kg), 2023-2028
Table 46. Bio X Cell Corporate Summary
Table 47. Bio X Cell Anti-PD-1 Antibody Product Offerings
Table 48. Bio X Cell Anti-PD-1 Antibody Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 49. Thermo Fisher Corporate Summary
Table 50. Thermo Fisher Anti-PD-1 Antibody Product Offerings
Table 51. Thermo Fisher Anti-PD-1 Antibody Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 52. InvivoGen Corporate Summary
Table 53. InvivoGen Anti-PD-1 Antibody Product Offerings
Table 54. InvivoGen Anti-PD-1 Antibody Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 55. BioVision Inc Corporate Summary
Table 56. BioVision Inc Anti-PD-1 Antibody Product Offerings
Table 57. BioVision Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 58. Abcam Corporate Summary
Table 59. Abcam Anti-PD-1 Antibody Product Offerings
Table 60. Abcam Anti-PD-1 Antibody Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 61. Bristol-Myers Squibb (BMS) Corporate Summary
Table 62. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product Offerings
Table 63. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 64. Merck Corporate Summary
Table 65. Merck Anti-PD-1 Antibody Product Offerings
Table 66. Merck Anti-PD-1 Antibody Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 67. Ono Pharmaceutical Co., Ltd Corporate Summary
Table 68. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Offerings
Table 69. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 70. Lilly Corporate Summary
Table 71. Lilly Anti-PD-1 Antibody Product Offerings
Table 72. Lilly Anti-PD-1 Antibody Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 73. Chugai Pharmaceutical Co., Ltd Corporate Summary
Table 74. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Offerings
Table 75. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 76. BeiGene Corporate Summary
Table 77. BeiGene Anti-PD-1 Antibody Product Offerings
Table 78. BeiGene Anti-PD-1 Antibody Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 79. Abbvie Corporate Summary
Table 80. Abbvie Anti-PD-1 Antibody Product Offerings
Table 81. Abbvie Anti-PD-1 Antibody Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 82. TG Therapeutics, Inc Corporate Summary
Table 83. TG Therapeutics, Inc Anti-PD-1 Antibody Product Offerings
Table 84. TG Therapeutics, Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 85. Novartis Corporate Summary
Table 86. Novartis Anti-PD-1 Antibody Product Offerings
Table 87. Novartis Anti-PD-1 Antibody Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 88. Arcus Biosciences Corporate Summary
Table 89. Arcus Biosciences Anti-PD-1 Antibody Product Offerings
Table 90. Arcus Biosciences Anti-PD-1 Antibody Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 91. Sino Biological Inc Corporate Summary
Table 92. Sino Biological Inc Anti-PD-1 Antibody Product Offerings
Table 93. Sino Biological Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 94. 3SBio Inc Corporate Summary
Table 95. 3SBio Inc Anti-PD-1 Antibody Product Offerings
Table 96. 3SBio Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$, Mn) and Average Price (USD/g) (2017-2022)
Table 97. Anti-PD-1 Antibody Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 98. Global Anti-PD-1 Antibody Capacity Market Share of Key Manufacturers, 2020-2022
Table 99. Global Anti-PD-1 Antibody Production by Region, 2017-2022 (Kg)
Table 100. Global Anti-PD-1 Antibody Production by Region, 2023-2028 (Kg)
Table 101. Anti-PD-1 Antibody Market Opportunities & Trends in Global Market
Table 102. Anti-PD-1 Antibody Market Drivers in Global Market
Table 103. Anti-PD-1 Antibody Market Restraints in Global Market
Table 104. Anti-PD-1 Antibody Raw Materials
Table 105. Anti-PD-1 Antibody Raw Materials Suppliers in Global Market
Table 106. Typical Anti-PD-1 Antibody Downstream
Table 107. Anti-PD-1 Antibody Downstream Clients in Global Market
Table 108. Anti-PD-1 Antibody Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Anti-PD-1 Antibody Segment by Type
Figure 2. Anti-PD-1 Antibody Segment by Application
Figure 3. Global Anti-PD-1 Antibody Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-PD-1 Antibody Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-PD-1 Antibody Revenue, 2017-2028 (US$, Mn)
Figure 7. Anti-PD-1 Antibody Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Anti-PD-1 Antibody Revenue in 2021
Figure 9. By Type - Global Anti-PD-1 Antibody Sales Market Share, 2017-2028
Figure 10. By Type - Global Anti-PD-1 Antibody Revenue Market Share, 2017-2028
Figure 11. By Type - Global Anti-PD-1 Antibody Price (USD/g), 2017-2028
Figure 12. By Application - Global Anti-PD-1 Antibody Sales Market Share, 2017-2028
Figure 13. By Application - Global Anti-PD-1 Antibody Revenue Market Share, 2017-2028
Figure 14. By Application - Global Anti-PD-1 Antibody Price (USD/g), 2017-2028
Figure 15. By Region - Global Anti-PD-1 Antibody Sales Market Share, 2017-2028
Figure 16. By Region - Global Anti-PD-1 Antibody Revenue Market Share, 2017-2028
Figure 17. By Country - North America Anti-PD-1 Antibody Revenue Market Share, 2017-2028
Figure 18. By Country - North America Anti-PD-1 Antibody Sales Market Share, 2017-2028
Figure 19. US Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Anti-PD-1 Antibody Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Anti-PD-1 Antibody Sales Market Share, 2017-2028
Figure 24. Germany Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 25. France Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Anti-PD-1 Antibody Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Anti-PD-1 Antibody Sales Market Share, 2017-2028
Figure 33. China Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 37. India Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Anti-PD-1 Antibody Revenue Market Share, 2017-2028
Figure 39. By Country - South America Anti-PD-1 Antibody Sales Market Share, 2017-2028
Figure 40. Brazil Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Anti-PD-1 Antibody Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Anti-PD-1 Antibody Sales Market Share, 2017-2028
Figure 44. Turkey Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Anti-PD-1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 48. Global Anti-PD-1 Antibody Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Anti-PD-1 Antibody by Region, 2021 VS 2028
Figure 50. Anti-PD-1 Antibody Industry Value Chain
Figure 51. Marketing Channels


More Publications